N0018926RB011 - Drug Demand Reduction Program, Fentanyl/Norfentanyl Immunoassay Reagent Kits
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAVSUP FLT LOG CTR NORFOLK
Contract Value
Not provided
Codes & Classification
Solicitation Number
N0018926RB011
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents4
The Department of the Navy, through the NAVSUP Fleet Logistics Center Norfolk, has issued a combined synopsis/solicitation (Procurement Identifier: N0018926RB011) for the supply of FDA-approved and quality management-documented Fentanyl/Norfentanyl Immunoassay Reagent Kits. This procurement supports the Department of War’s Drug Demand Reduction Program (DDRP), with the overarching goal of enhancing the detection and deterrence of fentanyl and norfentanyl use through robust, high-throughput urine testing.
The scope of this requirement encompasses the provision of immunoassay reagent kits specifically designed for compatibility with the Beckman Coulter AU5800 series analyzers, which are currently installed at the designated facility. The kits must be capable of reliably detecting fentanyl and norfentanyl in human urine samples, ensuring compliance with Food & Drug Administration (FDA) standards and documented quality management protocols. The anticipated ordering period for this contract is five (5) years, with an estimated testing volume of up to 500,000 tests per month, reflecting the program’s significant operational scale and the critical nature of timely, accurate substance detection.
Key deliverables include the consistent supply of reagent kits that meet all technical and regulatory requirements, as detailed in the attached Statement of Work and solicitation documents. Contractors must ensure that all products are fully compatible with the Beckman Coulter AU5800 series systems and are supported by appropriate documentation to demonstrate FDA approval and adherence to quality management standards.
This opportunity is classified under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022 version) and Product Service Code 6550. There are no set-aside restrictions associated with this solicitation, making it open to all qualified vendors. The place of performance is Portsmouth, Virginia, United States.
The contracting activity is managed by NAVSUP Fleet Logistics Center Norfolk, a federal office under the Department of Defense and the Department of the Navy. Interested parties are encouraged to review the full solicitation and Statement of Work, available via the provided SAM.gov link. The primary point of contact for this procurement is Austin Waller, Contracting Specialist, who can be reached at [email protected] or by phone at 771-229-2370.
The solicitation was posted on May 27, 2026, and responses are due by June 26, 2026, at 16:06. Contractors considering this opportunity should ensure their capabilities align with the technical, regulatory, and volume requirements outlined, and should prepare to demonstrate compliance with all specified standards throughout the contract lifecycle.